New to shockwave or in pain for more than 3 months? Book a Telehealth to see if we can help you!
Lower back pain affects millions of people worldwide, with chronic conditions creating significant impacts on quality of life and daily functioning. At Unpain Clinic, we understand that patients need clear, evidence-based information about their treatment options. Extracorporeal Shock Wave Therapy (ESWT) has emerged as a promising non-invasive treatment for various lower back conditions, including chronic lower back pain, sciatica, herniated discs, and facet joint syndrome.
This comprehensive review examines the latest scientific research on shockwave therapy’s effectiveness for lower back conditions, providing you with the evidence you need to make informed decisions about your treatment.
Extracorporeal Shock Wave Therapy (ESWT) is a non-invasive medical treatment that uses acoustic waves to deliver energy to targeted areas in the body. Originally developed for breaking up kidney stones, this technology has been adapted for treating various musculoskeletal conditions.
The therapy works by delivering controlled energy pulses to injured tissues, triggering the body’s natural healing processes at the cellular level. There are two main types of shockwave therapy:
Radial ESWT (r-ESWT): Uses pneumatic pressure to create waves that spread outward from the point of contact
Focused ESWT (f-ESWT): Delivers concentrated energy to specific depths within tissues
The most comprehensive evidence comes from two major systematic reviews and meta-analyses that examined multiple randomized controlled trials:
Study 1: Meta-Analysis of 632 Patients (2023)
A groundbreaking systematic review analyzed 12 randomized controlled trials involving 632 patients with chronic lower back pain. The results demonstrated significant benefits:
• Pain Relief: Patients receiving shockwave therapy experienced significantly greater pain reduction compared to control groups at both 4 weeks (weighted mean difference = -1.04 points) and 12 weeks (weighted mean difference = -0.85 points) on standard pain scales
• Functional Improvement: Disability scores, measured by the Oswestry Disability Index, showed substantial improvement at 4 weeks (weighted mean difference = -4.22 points) and 12 weeks (weighted mean difference = -4.51 points)
• Safety Profile: No serious adverse effects were reported across any of the 12 studies
A second comprehensive review of 10 randomized controlled trials involving 455 patients provided additional confirmation:
• Short-term Pain Relief: Significant reduction in pain intensity at 1-month follow-up (standardized mean difference = -0.81)
• Disability Improvement: Notable improvement in disability scores at both 1-month and 3-month follow-ups
• Minimal Side Effects: No serious shockwave-related adverse events were reported
These studies demonstrate that shockwave therapy achieves what researchers call “minimal clinically important change” (MCIC) – meaning the improvements are not just statistically significant but also meaningful to patients in their daily lives.
Research specifically examining herniated discs has shown promising results:
• A 2018 study published in the Journal of Orthopedic Surgery and Research demonstrated that shockwave therapy was effective in treating lumbar disc herniation, showing significant pain reduction and improved functionality
• A 2023 comparative study found that both electromagnetic field therapy and shockwave therapy helped elderly patients with lumbar disc herniation achieve similar functional improvements
Emerging research reveals fascinating insights into how shockwave therapy may help with sciatic nerve problems:
• Cellular Mechanisms: Studies show that low-intensity shockwave therapy promotes recovery of sciatic nerve injury through activation of specific cellular pathways (YAP/TAZ signaling)
• Schwann Cell Activation: The therapy stimulates Schwann cells, which are crucial for nerve repair and regeneration
• Improved Nerve Conduction: Research demonstrates faster nerve conduction velocity and increased axonal regeneration with improved motor function
Recent breakthrough research specifically targeting facet joint pain shows exceptional promise:
2025 Randomized Controlled Trial Results
A prospective study of 128 patients with chronic lumbar facet syndrome confirmed by medical imaging showed remarkable outcomes:
•Dramatic Pain Reduction: 64.4% average reduction in pain scores at 12 months
•Functional Improvement: 42.3% improvement in disability scores compared to 12.5% in control groups
•Neuropathic Pain Relief: Significant improvement in nerve-related pain symptoms
•Tissue Healing: MRI follow-up showed resolution of bone marrow inflammation in 58.8% of treated patients
• No Side Effects: Zero adverse effects reported
Research has identified four distinct phases of how shockwave therapy promotes healing:
The therapy reduces pain through multiple pathways:
• Gate Control Theory: Stimulation of pain receptors activates the body’s natural “gate control” system, blocking pain signal transmission to the brain
• Substance P Reduction: Decreases levels of substance P and other pain-transmitting chemicals
• Endorphin Release: Promotes secretion of the body’s natural pain-relieving chemicals
• Anti-inflammatory Action: Significantly reduces inflammatory markers (IL-1, TNF-α, MMPs) in affected tissue
Shockwave therapy promotes healing through:
•Enhanced Blood Flow: Reopening of blocked small blood vessels improves tissue nutrition
•Cellular Stimulation: Activation of fibroblasts (cells responsible for tissue repair)
•Protein Synthesis: Increased production of collagen and other structural proteins
•Stem Cell Activation: Stimulation of the body’s own repair stem cells
Standard Parameters
•Energy Flux Density: 0.03-0.18 mJ/mm² (varies by condition and equipment)
•Pulse Frequency: 4-15 Hz
•Number of Pulses: 1,000-4,000 pulses per session
•Treatment Frequency: 1-2 sessions per week
•Duration: 3-6 weeks (typically 5-10 total sessions)
Treatment Areas
• Trigger points in lower back muscles
• Sacroiliac joint region
• Areas of maximum tenderness
• Specific anatomical landmarks based on condition
The research consistently shows that shockwave therapy has an excellent safety profile:
• No Serious Adverse Events: Across all major studies involving hundreds of patients, no serious complications were reported
• Minimal Side Effects: Occasional mild discomfort during treatment was the only reported side effect
• Non-Invasive: No surgical risks, anesthesia, or recovery time required
While generally safe, shockwave therapy should not be used in certain situations:
Absolute Contraindications
•Over the lungs, heart, or brain areas
•During pregnancy (over abdomen or lower back)
•Over areas with active infections
Relative Contraindications (Require Caution)
•Patients taking blood-thinning medications
•Recent corticosteroid injections (wait 4-6 weeks)
•Certain metabolic bone conditions
Research comparing shockwave therapy to standard treatments shows several advantages:
Compared to Medications
• No risk of side effects from NSAIDs or opioids
• Longer-lasting pain relief
• Addresses underlying tissue problems, not just symptoms
Compared to Injections
• Non-invasive approach with no injection risks
• No risk of infection or nerve damage
• Can be repeated safely as needed
Compared to Surgery
• No surgical risks or complications
• No recovery time or activity restrictions
• Significantly lower cost
Studies show that shockwave therapy provides benefits that continue to improve over time, with some research demonstrating sustained pain relief and functional improvement at 3-6 month follow-ups.
Research suggests shockwave therapy works best for patients with:
•Chronic lower back pain lasting more than 3 months
•Mechanical (non-inflammatory) back pain
•Localized trigger points or tender areas
•Failed response to conservative treatments
•Preference for non-invasive treatment options
Based on clinical studies:
•Week 1-2: Initial cellular responses begin
•Week 4: Significant pain reduction typically observed
•Week 8-12: Maximum functional improvement achieved
•3-6 Months: Sustained benefits with continued improvement
•Significant and sustained pain reduction
•Meaningful functional improvement
•Excellent safety profile
•Cost-effective treatment option
•No serious side effects or complications
This review is for educational purposes and should not replace professional medical consultation. Always consult with qualified healthcare providers before beginning any new treatment program.
Uran Berisha
Shockwave Expert
